Status:

WITHDRAWN

Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who Are High Risk For Inadequate Bowel Preparation

Lead Sponsor:

Motus GI Medical Technologies Ltd

Conditions:

Gastrointestinal Disease

Colorectal Cancer

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The primary objective of this multi-center, prospective, randomized controlled trial is to evaluate the bowel cleansing after Pure-Vu use in outpatient subjects at high risk for inadequate colon prepa...

Detailed Description

Total of 88 subjects (44 per arm) at high risk for inadequate colon preparation will be randomized and undergo procedure either in the Control arm (standard of care) or with the Pure-Vu System. Subje...

Eligibility Criteria

Inclusion

  • Adults \> age 22
  • Elective outpatient colonoscopy by participating gastroenterologist
  • Stool clarity grade 1-3 at presentation for colonoscopy

Exclusion

  • Not competent to consent
  • Bleeding disorder - known or suspected
  • Hereditary Gastrointestinal Cancer syndrome
  • Known PT INR \> 1.5
  • Know elevated PTT
  • Anti-platelet agent or anticoagulant (other than aspirin or nonsteroidal agent) which has not been stopped for the colonoscopy
  • Known platelet count \< 50,000
  • Known absolute neutrophil count \< 1,000
  • History of surgical colon resection
  • Pre-colonoscopy intent to enter terminal ileum
  • Prior incomplete colonoscopy due to technical \& non-bowel preparation related reasons
  • Regular use of non-topical steroid
  • Pregnant
  • Prisoner or institutionalized for any reason
  • Psychiatric illness greater than mild
  • Colonoscopy without anesthesia administered (MAC) sedation
  • Diverticulitis
  • Active inflammatory bowel disease (Crohn's, Ulcerative Colitis, or Indeterminate)
  • Known or suspected colon stricture

Key Trial Info

Start Date :

March 3 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04285008

Start Date

March 3 2020

End Date

April 15 2021

Last Update

June 25 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University in St. Louis

St Louis, Missouri, United States, 63110